EFFICACY OF SLGT2 DRUGS IN TYPE II DIABETES MELLITUS

Akhmentayeva D.A, Nurmaxan E.K, Minjasarova M.A

Klinik fanlar yilnomasi · 2024-yil

Annotatsiya

SGLT2 was first identified as glucose-lowering drugs due to the glucosuric effect of inhibitors and a good safety profile. Subsequently, the results of studies on the effects of drugs in this group on cardiovascular and renal function began to appear. This article will describe the results of treatment of patients with type 2 diabetes.

Maqola ma’lumotlari
MualliflarAkhmentayeva D.A, Nurmaxan E.K, Minjasarova M.A
JurnalKlinik fanlar yilnomasi
Nashr sanasi2024-06-21
Jild1
Son1
TilRus

Kalit so‘zlar

chronic heart failure, type 2 diabetes, SGLT-2 drugs, dapagliflozin., хроническая сердечная недостаточность, сахарный диабет II типа, SGLT2 терапия, дапаглифлозин, хроническая сердечная недостаточность, сахарный диабет II типа, SGLT2 терапия, дапаглифлозин

Ilmiy soha

Klinik fanlar yilnomasi jurnalidan boshqa maqolalar

Klinik fanlar yilnomasi — barcha maqolalar